Cargando…
Clinical and laboratory characteristics of drug-induced vasculitic syndromes
Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257446/ https://www.ncbi.nlm.nih.gov/pubmed/16207347 http://dx.doi.org/10.1186/ar1805 |
_version_ | 1782125808364552192 |
---|---|
author | Wiik, Allan |
author_facet | Wiik, Allan |
author_sort | Wiik, Allan |
collection | PubMed |
description | Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase–antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare. |
format | Text |
id | pubmed-1257446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-12574462005-10-19 Clinical and laboratory characteristics of drug-induced vasculitic syndromes Wiik, Allan Arthritis Res Ther Commentary Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase–antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare. BioMed Central 2005 2005-08-24 /pmc/articles/PMC1257446/ /pubmed/16207347 http://dx.doi.org/10.1186/ar1805 Text en Copyright © 2005 BioMed Central Ltd |
spellingShingle | Commentary Wiik, Allan Clinical and laboratory characteristics of drug-induced vasculitic syndromes |
title | Clinical and laboratory characteristics of drug-induced vasculitic syndromes |
title_full | Clinical and laboratory characteristics of drug-induced vasculitic syndromes |
title_fullStr | Clinical and laboratory characteristics of drug-induced vasculitic syndromes |
title_full_unstemmed | Clinical and laboratory characteristics of drug-induced vasculitic syndromes |
title_short | Clinical and laboratory characteristics of drug-induced vasculitic syndromes |
title_sort | clinical and laboratory characteristics of drug-induced vasculitic syndromes |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257446/ https://www.ncbi.nlm.nih.gov/pubmed/16207347 http://dx.doi.org/10.1186/ar1805 |
work_keys_str_mv | AT wiikallan clinicalandlaboratorycharacteristicsofdruginducedvasculiticsyndromes |